Newsroom - Cavidi

Reaction TimeNews and views from Cavidi

Keep in touch

Join our mailing list to help democratize detection.

Speed of Life podcast interviews Cavidi

22/11/2022

Cavidi launches novel platform technology - Exazym®

17/05/2021

To showcase of the potential utility of Exazym®, we have demon...

Nordic Collaboration for SARS-CoV-2 virology and serology testing

13/07/2020

Nordic virus monitoring and diagnostics’ companies Cavidi and ...

Olof Larsson joins Cavidi as R&D Director

09/04/2020

Olof has an academic background with a Ph.D. Pharmacology and a ...

COVID-19 and HIV how we can learn from pandemics

30/03/2020

In times of uncertainty and crisis, clear information saves live...

Walter Campos MBA, MSc, PhD Virology has been promoted to Commercial Director, Africa

06/03/2020

Walter Campos MBA, MSc, PhD Virology has been promoted to Commer...

Cavidi secures ALMI grant to expand presence in US market

22/05/2018

The gene therapy market in the United States is growing rapidly,...

Cavidi finalists in Uppsala Innovation Award 2018

21/04/2018

"It was an honour to be nominated especially when one sees the v...

Innovation success is mission possible at Cavidi

20/04/2018

01 02 03 04 05 06 07

Cavidi is Sweden’s leading supplier of viral load monitoring. Our technologies position Cavidi at the forefront of biomarker detection for disease areas where high sensitivity and precision are key. We draw on our over 30 years of experience and expertise on Reverse-Transcriptase based immunoassays. Cavidi also provides tools and kits for virus research to many of the world’s leading labs.

Clinical products in development

Research products

Contact

Close Menu